These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21868063)

  • 1. Association between statin use and lupus-like syndrome using spontaneous reports.
    de Jong HJ; Tervaert JW; Saldi SR; Vandebriel RJ; Souverein PC; Meyboom RH; van Loveren H; Klungel OH
    Semin Arthritis Rheum; 2011 Dec; 41(3):373-81. PubMed ID: 21868063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.
    Moulis G; Béné J; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL;
    Lupus; 2012 Jul; 21(8):885-9. PubMed ID: 22333565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus-like syndrome associated with statin therapy.
    Noël B; Panizzon RG
    Dermatology; 2004; 208(3):276-7. PubMed ID: 15118389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach.
    de Jong HJ; Saldi SR; Klungel OH; Vandebriel RJ; Souverein PC; Meyboom RH; Passier JL; van Loveren H; Cohen Tervaert JW
    PLoS One; 2012; 7(7):e41289. PubMed ID: 22844450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
    Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
    Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between statin therapy and tendon rupture: a case-control study.
    Beri A; Dwamena FC; Dwamena BA
    J Cardiovasc Pharmacol; 2009 May; 53(5):401-4. PubMed ID: 19454900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statins--the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database].
    Buajordet I; Madsen S; Olsen H
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3210-3. PubMed ID: 9411859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
    Fujimoto M; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-12 and - 18 in lupus-like syndrome patients with statin use: comment on: Association between statin use and lupus-like syndrome using spontaneous reports.
    Park SJ; Shin JI
    Semin Arthritis Rheum; 2012 Jun; 41(6):e2-3. PubMed ID: 22405028
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
    Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
    Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.
    Noël B
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):17-24. PubMed ID: 17207162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.
    Marie I; Delafenêtre H; Massy N; Thuillez C; Noblet C;
    Arthritis Rheum; 2008 Mar; 59(3):367-72. PubMed ID: 18311771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and the risk of pancreatic cancer: a population-based case-control study.
    Chiu HF; Chang CC; Ho SC; Wu TN; Yang CY
    Pancreas; 2011 Jul; 40(5):669-72. PubMed ID: 21654539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.